The human gut microbial metabolome modulates fungal growth via the TOR signaling pathway

mSphere

Volumn 2, Issue 6, 2017, Pages

  García, Carlos ^a   Tebbji, Faiza ^a   Daigneault, Michelle ^b   Liu, Ning Ning ^c   Köhler, Julia R ^c   Allen Vercoe, Emma ^b   Sellama, Adnane ^d  

^a University Laval   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

Antifungal activity; Candida albicans; Gut microbial metabolome; TOR pathway

Indexed keywords

EID: 85041493843     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00555-17     Document Type: Article

References (46)

1. Nucci M, Anaissie E. 2001. Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959-1967. https://doi.org/10.1086/323759
2. Miranda LN, van der Heijden IM, Costa SF, Sousa AP, Sienra RA, Gobara S, Santos CR, Lobo RD, Pessoa VP, Jr, Levin AS. 2009. Candida colonisation as a source for candidaemia. J Hosp Infect 72:9-16. https://doi.org/ 10.1016/j.jhin.2009.02.009
3. Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, Drews O, Weichert W, Timmis KN, Schreiber S. 2008. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 43:831-841. https://doi.org/10.1080/0036 5520801935434
4. Underhill DM, Iliev ID. 2014. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 14: 405-416. https://doi.org/10.1038/nri3684
5. Sam QH, Chang MW, Chai LY. 2017. The fungal mycobiome and its interaction with gut bacteria in the host. Int J Mol Sci 18:330. https:// doi.org/10.3390/ijms18020330
6. Standaert-Vitse A, Sendid B, Joossens M, François N, Vandewalle-El Khoury P, Branche J, Van Kruiningen H, Jouault T, Rutgeerts P, Gower-Rousseau C, Libersa C, Neut C, Broly F, Chamaillard M, Vermeire S, Poulain D, Colombel JF. 2009. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol 104:1745-1753. https:// doi.org/10.1038/ajg.2009.225
7. Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard ML, Beaugerie L. 2017. Fungal microbiota dysbiosis in IBD. Gut 66:1039-1048. https://doi.org/10.1136/gutjnl-2015-310746
8. Hoarau G, Mukherjee PK, Gower-Rousseau C, Hager C, Chandra J, Retuerto MA, Neut C, Vermeire S, Clemente J, Colombel JF, Fujioka H, Poulain D, Sendid B, Ghannoum MA. 2016. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn's disease. mBio 7:e01250-16. https://doi.org/10.1128/mBio.01250-16
9. Liguori G, Lamas B, Richard ML, Brandi G, da Costa G, Hoffmann TW, Di Simone MP, Calabrese C, Poggioli G, Langella P, Campieri M, Sokol H. 2016. Fungal dysbiosis in mucosa-associated microbiota of Crohn's disease patients. J Crohns Colitis 10:296-305. https://doi.org/10.1093/ecco-jcc/jjv209
10. Chehoud C, Albenberg LG, Judge C, Hoffmann C, Grunberg S, Bittinger K, Baldassano RN, Lewis JD, Bushman FD, Wu GD. 2015. Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 21:1948-1956. https://doi.org/10.1097/MIB. 0000000000000454
11. Sharon G, Garg N, Debelius J, Knight R, Dorrestein PC, Mazmanian SK. 2014. Specialized metabolites from the microbiome in health and disease. Cell Metab 20:719-730. https://doi.org/10.1016/j.cmet.2014.10. 016
12. Antunes LC, McDonald JA, Schroeter K, Carlucci C, Ferreira RB, Wang M, Yurist-Doutsch S, Hira G, Jacobson K, Davies J, Allen-Vercoe E, Finlay BB. 2014. Antivirulence activity of the human gut metabolome. mBio 5:e01183-14. https://doi.org/10.1128/mBio.01183-14
13. Gantois I, Ducatelle R, Pasmans F, Haesebrouck F, Hautefort I, Thompson A, Hinton JC, Van Immerseel F. 2006. Butyrate specifically downregulates Salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol 72:946-949. https://doi.org/10.1128/AEM.72.1.946-949. 2006
14. Kamada N, Chen GY, Inohara N, Núñez G. 2013. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 14:685-690. https://doi.org/10.1038/ni.2608
15. Morales DK, Hogan DA. 2010. Candida albicans interactions with bacteria in the context of human health and disease. PLoS Pathog 6:e1000886. https://doi.org/10.1371/journal.ppat.1000886
16. Nguyen LN, Lopes LC, Cordero RJ, Nosanchuk JD. 2011. Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages. J Antimicrob Chemother 66:2573-2580. https://doi.org/10. 1093/jac/dkr358
17. Antunes LC, Han J, Ferreira RB, Lolić P, Borchers CH, Finlay BB. 2011. Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother 55:1494-1503. https://doi.org/10.1128/AAC. 01664-10
18. Yen S, McDonald JA, Schroeter K, Oliphant K, Sokolenko S, Blondeel EJ, Allen-Vercoe E, Aucoin MG. 2015. Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities. J Proteome Res 14:1472-1482. https://doi.org/10. 1021/pr5011247
19. Vogt SL, Peña-Díaz J, Finlay BB. 2015. Chemical communication in the gut: effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens. Anaerobe 34:106-115. https://doi.org/10.1016/j. anaerobe.2015.05.002
20. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E. 2013. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: "RePOOPulating" the gut. Microbiome 1:3. https://doi.org/10.1186/2049-2618-1-3
21. Martz SL, McDonald JA, Sun J, Zhang YG, Gloor GB, Noordhof C, He SM, Gerbaba TK, Blennerhassett M, Hurlbut DJ, Allen-Vercoe E, Claud EC, Petrof EO. 2015. Administration of defined microbiota is protective in a murine Salmonella infection model. Sci Rep 5:16094. https://doi.org/10. 1038/srep16094
22. Suhr MJ, Hallen-Adams HE. 2015. The human gut mycobiome: pitfalls and potentials-a mycologist's perspective. Mycologia 107:1057-1073. https://doi.org/10.3852/15-147
23. Cui L, Morris A, Ghedin E. 2013. The human mycobiome in health and disease. Genome Med 5:63. https://doi.org/10.1186/gm467
24. Roemer T, Jiang B, Davison J, Ketela T, Veillette K, Breton A, Tandia F, Linteau A, Sillaots S, Marta C, Martel N, Veronneau S, Lemieux S, Kauffman S, Becker J, Storms R, Boone C, Bussey H. 2003. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol Microbiol 50:167-181. https://doi.org/10.1046/j. 1365-2958.2003.03697.x
25. Loewith R, Hall MN. 2011. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics 189:1177-1201. https://doi.org/10.1534/ genetics.111.133363
26. Cruz MC, Goldstein AL, Blankenship J, Del Poeta M, Perfect JR, McCusker JH, Bennani YL, Cardenas ME, Heitman J. 2001. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrob Agents Chemother 45:3162-3170. https://doi.org/10.1128/AAC.45.11.3162-3170.2001
27. Chowdhury T, Köhler JR. 2015. Ribosomal protein s6 phosphorylation is controlled by TOR and modulated by PKA in Candida albicans. Mol Microbiol 98:384-402. https://doi.org/10.1111/mmi.13130
28. Crespo JL, Hall MN. 2002. Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae. Microbiol Mol Biol Rev 66:579-591. https://doi.org/10.1128/MMBR.66.4.579-591.2002
29. Inoki K, Ouyang H, Li Y, Guan KL. 2005. Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev 69:79-100. https://doi.org/10.1128/MMBR.69.1.79-100.2005
30. Gray JV, Petsko GA, Johnston GC, Ringe D, Singer RA, Werner-Washburne M. 2004. "Sleeping Beauty": quiescence in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 68:187-206. https://doi.org/10.1128/MMBR.68.2. 187-206.2004
31. Bastidas RJ, Heitman J, Cardenas ME. 2009. The protein kinase Tor1 regulates adhesin gene expression in Candida albicans. PLoS Pathog 5:e1000294. https://doi.org/10.1371/journal.ppat.1000294
32. Ramachandra S, Linde J, Brock M, Guthke R, Hube B, Brunke S. 2014. Regulatory networks controlling nitrogen sensing and uptake in Candida albicans. PLoS One 9:e92734. https://doi.org/10.1371/journal.pone. 0092734
33. Morschhäuser J. 2011. Nitrogen regulation of morphogenesis and protease secretion in Candida albicans. Int J Med Microbiol 301:390-394. https://doi.org/10.1016/j.ijmm.2011.04.005
34. Cardenas ME, Cutler NS, Lorenz MC, Di Como CJ, Heitman J. 1999. The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev 13:3271-3279. https://doi.org/10.1101/gad.13.24.3271
35. Hardwick JS, Kuruvilla FG, Tong JK, Shamji AF, Schreiber SL. 1999. Rapamycin-modulated transcription defines the subset of nutrientsensitive signaling pathways directly controlled by the Tor proteins. Proc Natl Acad Sci U S A 96:14866-14870. https://doi.org/10.1073/pnas.96.26. 14866
36. Boer VM, de Winde JH, Pronk JT, Piper MD. 2003. The genome-wide transcriptional responses of Saccharomyces cerevisiae grown on glucose in aerobic chemostat cultures limited for carbon, nitrogen, phos-phorus, or sulfur. J Biol Chem 278:3265-3274. https://doi.org/10.1074/ jbc.M209759200
37. Rodaki A, Bohovych IM, Enjalbert B, Young T, Odds FC, Gow NA, Brown AJ. 2009. Glucose promotes stress resistance in the fungal pathogen Candida albicans. Mol Biol Cell 20:4845-4855. https://doi.org/10.1091/ mbc.E09-01-0002
38. Brestoff JR, Artis D. 2013. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 14:676-684. https:// doi.org/10.1038/ni.2640
39. Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, Zhan X, Simms-Waldrip TR, Xie Y, Hooper LV, Koh AY. 2015. Activation of HIF-1alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med 21:808-814. https://doi.org/10.1038/nm.3871
40. Louis P, Flint HJ. 2009. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294:1-8. https://doi.org/10.1111/j.1574-6968.2009.01514.x
41. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. 2002. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217:133-139. https://doi.org/10.1111/j.1574-6968.2002.tb11467.x
42. Larsbrink J, Rogers TE, Hemsworth GR, McKee LS, Tauzin AS, Spadiut O, Klinter S, Pudlo NA, Urs K, Koropatkin NM, Creagh AL, Haynes CA, Kelly AG, Cederholm SN, Davies GJ, Martens EC, Brumer H. 2014. A discrete genetic locus confers xyloglucan metabolism in select human gut Bacteroidetes. Nature 506:498-502. https://doi.org/10.1038/nature12907
43. McDonald JA, Schroeter K, Fuentes S, Heikamp-Dejong I, Khursigara CM, de Vos WM, Allen-Vercoe E. 2013. Evaluation of microbial community reproducibility, stability and composition in a human distal gut chemostat model. J Microbiol Methods 95:167-174. https://doi.org/10.1016/j. mimet.2013.08.008
44. Guillemette T, Sellam A, Simoneau P. 2004. Analysis of a nonribosomal peptide synthetase gene from Alternaria brassicae and flanking genomic sequences. Curr Genet 45:214-224. https://doi.org/10.1007/s00294-003-0479-z
45. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15-21. https://doi.org/10.1093/bioinformatics/bts635
46. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L. 2012. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7:562-578. https://doi.org/10.1038/nprot.2012.016